Cornerstone Investment Partners LLC trimmed its position in shares of Citigroup Inc. (NYSE:C – Get Rating) by 1.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 657,674 shares of the company’s stock after selling 8,143 shares during the period. Citigroup makes up approximately 2.0% of Cornerstone Investment Partners LLC’s holdings, making the stock its 29th largest holding. Cornerstone Investment Partners LLC’s holdings in Citigroup were worth $27,405,000 at the end of the most recent reporting period.
Several other large investors have also recently added to or reduced their stakes in C. Horan Securities Inc. boosted its position in shares of Citigroup by 18.0% during the 2nd quarter. Horan Securities Inc. now owns 1,269 shares of the company’s stock valued at $64,000 after acquiring an additional 194 shares in the last quarter. Zullo Investment Group Inc. grew its stake in shares of Citigroup by 5.3% in the 2nd quarter. Zullo Investment Group Inc. now owns 3,839 shares of the company’s stock valued at $177,000 after purchasing an additional 194 shares during the period. Rise Advisors LLC raised its holdings in shares of Citigroup by 30.6% in the 2nd quarter. Rise Advisors LLC now owns 846 shares of the company’s stock worth $39,000 after buying an additional 198 shares in the last quarter. Founders Capital Management lifted its position in shares of Citigroup by 28.6% during the 2nd quarter. Founders Capital Management now owns 900 shares of the company’s stock worth $41,000 after buying an additional 200 shares during the period. Finally, Clearview Wealth Advisors LLC lifted its position in shares of Citigroup by 11.7% during the 2nd quarter. Clearview Wealth Advisors LLC now owns 1,979 shares of the company’s stock worth $91,000 after buying an additional 208 shares during the period. Institutional investors and hedge funds own 70.90% of the company’s stock.
Citigroup Stock Performance
Shares of NYSE:C opened at $51.12 on Wednesday. Citigroup Inc. has a 1-year low of $40.01 and a 1-year high of $69.11. The business has a 50-day moving average price of $47.04 and a two-hundred day moving average price of $47.61. The company has a current ratio of 0.94, a quick ratio of 0.93 and a debt-to-equity ratio of 1.49. The stock has a market capitalization of $99.01 billion, a P/E ratio of 7.35, a P/E/G ratio of 1.71 and a beta of 1.56.
Citigroup Announces Dividend
Analyst Ratings Changes
C has been the subject of several recent analyst reports. Deutsche Bank Aktiengesellschaft dropped their price objective on Citigroup from $52.00 to $46.00 in a research note on Friday, January 6th. Credit Suisse Group set a $54.00 target price on shares of Citigroup in a research report on Monday, October 10th. JPMorgan Chase & Co. boosted their price target on shares of Citigroup from $49.00 to $49.50 in a research report on Wednesday, November 2nd. The Goldman Sachs Group lowered shares of Citigroup from a “buy” rating to a “neutral” rating and dropped their price objective for the stock from $54.00 to $47.00 in a report on Monday, October 3rd. Finally, StockNews.com began coverage on shares of Citigroup in a research note on Wednesday, October 12th. They issued a “hold” rating for the company. One equities research analyst has rated the stock with a sell rating, eleven have given a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $57.42.
Citigroup, Inc is a holding company, which engages in the provision of financial products and services. It operates through the following segments: Global Consumer Banking, Institutional Clients Group, and Corporate and Other. The Global Consumer Banking segment provides traditional banking services to retail customers through retail banking, including commercial banking, and Citi-branded cards and Citi retail services.
- Get a free copy of the StockNews.com research report on Citigroup (C)
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
- 3 Retail Stocks Ringing the Register in 2023
Receive News & Ratings for Citigroup Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Citigroup and related companies with MarketBeat.com's FREE daily email newsletter.